Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)

Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)

This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.

Inclusion Criteria:

• Written Informed Consent
• Male
• 18-70 years old
• Presentation with symptoms suggestive of obstructive sleep apnea
• Diagnostic sleep study
• Blood draw

Exclusion Criteria:

• Prior (within past year) or current therapy for sleep apnea
• Use of opioid pain medication, steroids or allopurinol (within past 30 days)
• Use of chronic anti-inflammatory drugs (within past 7 days)
• Active cancer under current treatment or monitoring